ALFA Filings
Every announcement, straight from the exchange
Every Shilpa Medicare other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements with these filters
Shilpa Medicare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Shilpa Medicare Ltd KMP Alpesh Maheshkumar Dalal sold 4,000 equity shares via market sale. The transaction was valued at Rs.0.42 Crore and executed on the NSE.
Shilpa Medicare received a 'Crisil ESG 59' rating from CRISIL ESG Ratings for FY2026. This is a routine regulatory disclosure under Regulation 30 with no financial implications.
Shilpa Medicare has dispatched letters to shareholders with unregistered emails, providing web-links to access the Annual Report and Notice of the 39th Annual General Meeting.
Shilpa Medicare Limited filed its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms overall regulatory compliance with no material deviations or penalties.
Shilpa Medicare Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. Issued by KFin Technologies Limited, the certificate confirms that security details for dematerialized and rematerialized shares have been furnished to the relevant stock exchanges.